- Investing Ideas
- Japanese Pharmaceuticals & Biotech Healthy potentially undervalued
Japanese Pharmaceuticals & Biotech Healthy potentially undervalued
Results
8
Companies which are potentially undervalued and in an acceptable financial position.
8 companies
Kissei Pharmaceutical
Market Cap: JP¥196.9b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥4,750.00
7D
1.1%
1Y
25.7%
Astellas Pharma
Market Cap: JP¥4.6t
Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.
4503
JP¥2,570.00
7D
0.4%
1Y
92.4%
Shionogi
Market Cap: JP¥2.7t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥3,213.00
7D
-4.8%
1Y
33.5%
Otsuka Holdings
Market Cap: JP¥5.6t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥10,685.00
7D
1.9%
1Y
61.6%
Daiichi Sankyo Company
Market Cap: JP¥5.5t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥3,000.00
7D
9.8%
1Y
-5.8%
Santen Pharmaceutical
Market Cap: JP¥563.6b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥1,752.00
7D
-3.0%
1Y
24.7%
Tsumura
Market Cap: JP¥279.2b
Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.
4540
JP¥3,746.00
7D
-0.5%
1Y
-14.7%
PeptiDream
Market Cap: JP¥154.0b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥1,192.00
7D
0.7%
1Y
-36.5%